Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-07-11)Premium Content

Gilead Sciences Inc (GILD)

2014-09-19@12:43:13 ET
Hetero Enters License Agreement With Gilead Sciences Inc., USA to Produce Generic Sofosbuvir for Treatment of Chronic Hepatitis C (ABW)

2014-09-19@12:06:17 ET
PDL BioPharma is Among the Companies in the Biotechnology Industry With the Highest Forward Earnings Yield (PDLI, SCLN, GILD) (F70)

2014-09-19@09:32:32 ET
Sequent Scientific inks licensing agreement with Gilead Sciences for new Hepatitis C drug (ABW)

2014-09-19@09:29:56 ET
Strides Arcolab surges on partnering with Gilead to produce and distribute Hepatitis C drug (ABW)

2014-09-19@08:15:00 ET
Biotech Companies Pushing Sector Higher With Recent Therapeutic Advancements & Patent Approvals - Company Wins Summary Judgment For Prodrug Patent (PRN)

2014-09-19@08:11:05 ET
Sector Update: Health-Care Shares Lower in Pre-Market Trade (MID)

2014-09-19@08:10:39 ET
Sector Update: Health Care (MID)

2014-09-19@06:23:01 ET
European Commission Grants Marketing Authorization for Gilead's Zydelig(R) (Idelalisib) for the Treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma (BIZ)

2014-09-18@23:24:20 ET
Gilead briefs govt about their licensing agreements with Pharmaceutical Manufacters (ABW)

2014-09-18@18:47:34 ET
HETERO DRUGS SIGNS UP WITH GILEAD (ABW)

2014-09-18@09:51:18 ET
Complete tech transfer important to enhance mfg capabilities in pharma: Sitharaman (ABW)

2014-09-18@09:17:41 ET
Gilead Sciences (GILD) Trading Near $99.95 Support Level (FBM)

2014-09-18@04:25:16 ET
Market Maker Surveillance Report. EPGL, CMCSA, GILD, YHOO, MSFT, VALE, Bearishly Biased Price Friction For Wednesday, September 17th 2014 (MTO)

2014-09-18@01:45:35 ET
Gilead Inks Generic Licensing Pacts to Increase Access to Hepatitis C Treatments in Developing Countries (CLM)

2014-09-17@14:07:59 ET
Strides Arcolab firms up on partnering with Gilead to produce and distribute Hepatitis C drug (ABW)

2014-09-17@14:04:36 ET
Zydus inks pact with Gilead Sciences to produce and distribute Hepatitis C drug (ABW)

2014-09-17@14:00:16 ET
Strides Arcolab partners with Gilead to produce and distribute Hepatitis C drug (ABW)

2014-09-17@13:54:57 ET
Cipla enters into non-exclusive licensing agreement with Gilead (ABW)

2014-09-17@13:54:33 ET
Cipla advances on entering into non-exclusive licensing agreement with Gilead (ABW)